3 Beaten-Down Biotech Stocks -- Can They Recover?
Look out below for these tumbling biotech stocks. Shares of Atea Pharmaceuticals (NASDAQ: AVIR), Omeros (NASDAQ: OMER), and Novavax (NASDAQ: NVAX) were big winners for investors this year right up until they weren't.
When stocks fall, they tend to fall hard. For reasons of their own, each of these stocks has given up more than half their value in 2021.
Investors running for the exits don't always have time to examine the reasons they're stampeding. Big sell-offs can create terrific bargains this way. Here's a closer look at what happened to these three stocks to gauge their odds of recovery.
Source Fool.com
